Skip to main content

Startup Support

Image
VentureStudio Logo

The Vanderbilt VentureStudio is the place to go for support when planning, launching, and growing your next startup company to commercialize a Vanderbilt innovation.

Support services include business model development and validation, financial modeling, proof of concept testing, company formation and governance, and investor engagement.

About CTTC

Image
Commercialization Process

Vanderbilt Center for Technology Transfer and Commercialization's mission is to provide professional commercialization services to the Vanderbilt community, thus optimizing the flow of innovation to the marketplace and generating revenue that supports future research activities, while having a positive impact on society.

Faculty / Researcher

Image
Faculty / Researcher

CTTC bridges the gap between academia and industry by moving innovative products from the lab bench to the marketplace. We accomplish this by:

  • serving as a conduit for the transfer of promising Vanderbilt technologies to industry;
  • contributing to regional economic development by licensing locally and supporting new venture creation; and
  • encouraging greater collaboration between academia and industry.

Industry Partners

Image
Industry Partners

CTTC is the conduit through which companies access technologies that are developed while conducting research and caring for patients at Vanderbilt. We work closely with faculty researchers to evaluate, protect, and license inventions to companies, which they then develop into new products that benefit society.


 

Commercialization Impact

10-Year Snapshot

  • 10526 MTAs Reviewed
  • 1812 Inventions Disclosed
  • 593 U.S. Patents Issued
  • 923 Licenses Executed
  • $286.4M Revenue Generated
  • 61 Startups Launched

Commercialization Spotlight

Inventor Spotlight

Benoit Dawant, Ph.D., Cornelius Vanderbilt Professor of Electrical and Computer Engineering and Director of VISE. His main research interests include medical image processing and analysis. Current projects include the development of algorithms and systems to assist in the placement of deep brain stimulators used for the treatment of Parkinson’s disease and other movement disorders, the placement of cochlear implants used to treat hearing disorders, or the creation of radiation therapy plans for the treatment of cancer. Dr. Dawant is a co-founder of two spinoff companies: Pathfinder Therapeutics, Inc. and  Neurotargeting, LLC.

Quick LInks